• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts.

作者信息

Fields K K, Elfenbein G J, Perkins J B, Moscinski L C

机构信息

Department of Internal Medicine, University of South Florida College of Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa 33612, USA.

出版信息

Ann N Y Acad Sci. 1995 Dec 29;770:288-304. doi: 10.1111/j.1749-6632.1995.tb31062.x.

DOI:10.1111/j.1749-6632.1995.tb31062.x
PMID:8597367
Abstract
摘要

相似文献

1
High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts.高剂量与标准剂量化疗治疗乳腺癌：当前概念综述
Ann N Y Acad Sci. 1995 Dec 29;770:288-304. doi: 10.1111/j.1749-6632.1995.tb31062.x.
2
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer.确定新型大剂量化疗方案在高危乳腺癌治疗中的作用。
Semin Oncol. 1998 Apr;25(2 Suppl 4):1-6; discussion 45-8.
3
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
Semin Oncol. 1993 Oct;20(5 Suppl 6):59-66.
4
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.美法仑、噻替派和紫杉醇多周期治疗后序贯米托蒽醌、噻替派和紫杉醇并采用自体造血细胞支持治疗转移性乳腺癌的可行性研究
Clin Cancer Res. 1999 Nov;5(11):3411-8.
5
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.在转移性乳腺癌中，在紫杉醇、美法仑、环磷酰胺、噻替派和卡铂（CTCb）序贯大剂量化疗方案并伴有外周血祖细胞支持的情况下，实现快速植入所需的CD34+细胞剂量。
J Hematother Stem Cell Res. 1999 Aug;8(4):357-63. doi: 10.1089/152581699320117.
6
A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle.一项针对符合单周期入选标准的转移性乳腺癌患者进行的两周期高剂量化疗联合自体干细胞支持的II期研究。
Bone Marrow Transplant. 2000 Mar;25(5):519-24. doi: 10.1038/sj.bmt.1702172.
7
High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.大剂量米托蒽醌联合噻替派、环磷酰胺及自体干细胞解救治疗高危Ⅱ期和Ⅲ期乳腺癌。德国GABG-4/EH-93研究。
Bone Marrow Transplant. 1996 Sep;18 Suppl 1:S24-5.
8
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.大剂量化疗及自体干细胞救援用于转移性乳腺癌：与单次移植相比，串联移植的生存期更优。
Am J Clin Oncol. 2005 Jun;28(3):281-8. doi: 10.1097/01.coc.0000156917.43490.65.
9
A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.一项关于持续输注紫杉醇以增强高剂量环磷酰胺和塞替派加干细胞救援治疗晚期乳腺癌患者的I期剂量递增试验。
Cancer. 1998 Oct 15;83(8):1540-5.
10
Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.一项在IV期乳腺癌中采用包含环磷酰胺、噻替派和卡铂的多疗程高剂量化疗方案的II期研究。
Bone Marrow Transplant. 2001 Jul;28(2):173-80. doi: 10.1038/sj.bmt.1703105.

引用本文的文献

1
Patient Characteristics Associated With Chemotherapy-Induced Peripheral Neuropathy Severity in a Phase II Clinical Trial: A Retrospective Analysis.在一项 II 期临床试验中与化疗诱导的周围神经病变严重程度相关的患者特征：回顾性分析。
Oncologist. 2023 Jul 5;28(7):604-608. doi: 10.1093/oncolo/oyad062.
2
Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancer.
Med Oncol. 1999 Apr;16(1):17-22. doi: 10.1007/BF02787354.